# Trial of Trastuzumab Deruxtecan in Previously Treated HER2

> **NCT06750484** · PHASE2 · RECRUITING · sponsor: **Yale University** · enrollment: 40 (estimated)

## Conditions studied

- Breast Cancer Metastatic

## Interventions

- **DRUG:** Trastuzumab Deruxtecan

## Key facts

- **NCT ID:** NCT06750484
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-06-20
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-05-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06750484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06750484, "Trial of Trastuzumab Deruxtecan in Previously Treated HER2". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06750484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*